Most GI groups don’t have a breath-testing problem. They have a breath-testing program problem. Kits get ordered. Curves come back, some of the time. Turnaround is “fine.” But ask a harder question — what is breath testing actually doing for our patients, providers, and practice? — and the answers get fuzzy. If that sounds familiar,…
Beyond the Gut ARTICLE 02 · RHEUMATOLOGY See the full series → For many of your systemic sclerosis patients, the gut is the most active disease site. Up to 90% develop gastrointestinal involvement, and SIBO is one of the most common and most treatable problems. This article is for you as a gastroenterologist. The goal…
Interpreting your score A directional view of where your program stands today 0 – 34 High opportunity Structural change likely required 35 – 54 Mixed performance Focus on the weakest domain first 55 – 70 Strong foundation Tighten remaining gaps and benchmark Score bands from the Breath Testing Done Right playbook. From there, useful next…
Beyond the Gut ARTICLE 01 · ENDOCRINOLOGY See the full series → Small intestinal bacterial overgrowth (SIBO) is still labeled a “GI diagnosis,” but your SIBO patients live in endocrine, allergy, rheumatology, and primary care clinics as well as yours. This first article in the Beyond the Gut series is written for you as a…
Sample stability is a crucial factor directly impacting the accuracy and reliability of hydrogen and methane breath testing results. Ensuring that samples remain stable throughout collection, storage, and transportation is essential for maintaining the integrity of the breath test, which detects conditions such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate…
CO2 correction is a vital component of accurate hydrogen and methane breath testing, and at CDI, we lead the way in implementing this essential process. By choosing CDI, healthcare providers can trust that they receive the most accurate, reliable, and transparent diagnostic results, enabling them to deliver exceptional patient care. Breath testing has become a…
A recent study and editorial in The American Journal of Gastroenterology (AJG) revisit a question that sits at the heart of modern functional GI care: When patients with disorders of gut–brain interaction (DGBI) say they’re “intolerant” to certain carbohydrates, how often is that backed by objective malabsorption—and does it matter clinically? The answer from this work: carbohydrate malabsorption…
Hydrogen and methane breath testing plays a critical role in diagnosing functional gastrointestinal disorders such as SIBO, IMO, and carbohydrate malabsorption. A breath test is ordered to answer a specific clinical question and guide next steps in patient care. When a test is never completed or returned, that diagnostic pathway stops short. Unreturned or unregistered…
Hydrogen and methane breath testing has become a staple in diagnosing conditions like Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO). While effective, understanding the sensitivity and specificity of these tests is critical for interpreting results accurately. This article in our ongoing Breath Testing Done Right series delves into how sensitivity and specificity…
A newly published study from Swedish clinical researchers further confirms the diagnostic value of hydrogen and methane breath testing (HMBT) for Small Intestinal Bacterial Overgrowth (SIBO)—supporting the core science behind CDI’s non-invasive testing model. The 2025 study, Refined Lactulose Hydrogen Breath Test for Small Intestinal Bacterial Overgrowth Diagnosis Based on a Survey Among Experts, analyzed data from…
